September 30, 2022 — Read the latest edition of our monthly newsletter
July 29, 2022 — The UW ADRC offers one-year development projects that use its resources to advance the understanding, diagnosis, and/or treatment of Alzheimer’s disease. In the 2023-2024 period, the UW ADRC aims to fund 3-4 projects of up to $50,000. At least two awards will be reserved for junior applications (Postdoctoral fellows with appropriate senior collaborators or junior faculty up to the rank of Assistant Professor). Please see click the link for eligibility details and key dates, and disseminate widely.
July 28, 2022 — The UW ADRC is excited about the official launch of the Seattle Alzheimer’s Disease Brain Cell Atlas (SEA-AD) web product (SEA-AD.org) and the first public release of the project’s data. This release is an important new resource for the Alzheimer’s community. The SEA-AD is a NIA-funded collaboration between the Allen Brain Institute, UW Medicine, and Kaiser Permanente Health Research Institute to create a higher resolution atlas of Alzheimer’s disease at the cellular level, in order to understand the early pathogenesis of AD, disease initiation, and cognitive decline.
Brian Kraemer awarded $250,000 by Washington Research Foundation to develop small molecules to treat Alzheimer’s disease
April 14, 2022 — "WRF’s generous support has enabled us to make rapid progress on early-stage drug discovery work towards MSUT2-based therapeutics." - UW ADRC's Brian Kraemer, PhD
February 23, 2022 — Check out the newly funded ADRC Development Projects for 2022 - 2023. These projects, led by postdoctoral fellows and faculty members, use ADRC resources to advance the understanding, diagnosis, and/or treatment of Alzheimer’s disease.
January 21, 2022 — The newest edition explores the Memory Hub: A Place for Dementia-Friendly Community, Collaboration, and Impact and highlights new findings from ADRC research studies. Our fall communications intern, Emi Takayama brings you an article about what microglia - the immune cells of the brain - can tell us about personal Alzheimer's genetic risk. And, Dr. Angela Hanson of the Memory and Brain Wellness Center, shares her key takeaways from the 2021 Alzheimer's Association International Conference. Happy reading!
January 20, 2022 — The LBDA New Investigator Award is intended to support early career and new investigators in LBD who have not yet received an R01 award from the National Institutes of Health, to gather preliminary data for projects proposed in future LBDA grant applications. LBDA is seeking proposals for translational or clinical research studies using human subjects, biofluid/tissue samples, or existing clinical data sets to answer questions about LBD diagnosis, clinical management, and well-being of persons with LBD and family caregivers. Letter of Intent due: Feb. 18, 2022, 8:59 p.m. PT. Request for proposals at the link.
Upcoming on January 28: Garvey Institute for Brain Health Solutions - 1st Annual Meeting Public Talks
January 20, 2022 — The mission of the Garvey Institute is to improve the health for the millions of people at risk for and affected by mental health, substance use, and other brain health disorders. Please join us to learn about the current portfolio of exciting projects and initiatives and plans for furthering the work of the Institute. Learn more and RSVP at the link.
January 04, 2022 — Congratulations to Maggie Ramirez, PhD, MS, University of Washington for receiving an IMPACT Collaboratory Pilot Grant Award for her project 'Virtual Training for Latino Caregivers to Manage Symptoms of Dementia.' This pilot study will enable her to perform and refine adaptations of the STAR-VTF intervention for Latino care partners. STAR-VTF is a virtual adaptation of an efficacious intervention that teaches caregivers skills to reduce behavioral and psychological symptoms of dementia.
December 22, 2021 — The UW Huddle newsletter highlighted the National Alzheimer’s Coordinating Center. The NACC is directed by Walter Kukull, PhD, professor of Epidemiology at UW School of Public Health. The NACC collects data from the national network of Alzheimer’s Disease Research Centers, including the UW ADRC.